Strategies for the Design of Drugs Targeting RNA and RNA-Protein Complexes

Area of Science:

• Biochemistry
• Molecular Biology
• Drug Discovery

Background:

• Ribonucleic acid (RNA) molecules are crucial in gene replication and expression, often acting through specific three-dimensional structures.
• RNA's structural complexity, similar to proteins, presents unique opportunities for therapeutic intervention.
• Many RNA functions depend on interactions with RNA-binding proteins, making these complexes potential drug targets.

Purpose of the Study:

• To review rational approaches for developing RNA-binding compounds.
• To discuss potential RNA targets for therapeutic intervention.
• To explore advances in understanding RNA-small molecule and RNA-protein interactions.

Main Methods:

• Review of current scientific literature on RNA structure, function, and drug design.
• Analysis of RNA-protein interactions and RNA-small molecule binding mechanisms.
• Discussion of novel drug design strategies tailored for RNA.

Main Results:

• RNA's three-dimensional structure is key to its function and offers a target for drug development.
• Therapeutic strategies can target RNA structure to modulate protein interactions or directly inhibit complexes.
• Novel drug design approaches are needed due to fundamental differences between RNA and protein folding.

Conclusions:

• Targeting RNA's complex 3D structures represents a promising frontier in drug discovery.
• Understanding RNA-small molecule and RNA-protein interactions is vital for developing effective RNA-targeted therapeutics.
• This field holds potential to significantly expand the therapeutic landscape beyond protein-targeted drugs.